PYXS: Pyxis Oncology, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
1 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 0 | PYXS | Pyxis Oncology, Inc. | Gordonmd Global Investments Lp / Gordonmd Long Biased Master Fund Lp / Gordonmd Long Biased Gp Llc / Gordon Craig D | 10% Owner | 2026-10-01 | - | 55% |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-10-09 | 13G stake cut | GordonMD Global Investments LP | 16.40% | -1.10 pts | SEC |
| 2026-10-05 | New 13G stake | Coastlands Capital LP | 5.42% | SEC | |
| 2026-10-02 | 13G amendment | GordonMD Global Investments LP | 17.50% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.